ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

CRISPR update calms fears about off-target editing effects – Genetic Literacy Project

Genetic Literacy ProjectCRISPR update calms fears about off-target editing effectsGenetic Literacy ProjectA study last year involving just three mice raised fears that CRISPR-Cas9, the classic version of the genome editor, might be a big, stupid bloodh… Continue reading

2018-03-09 Michael Zand NEWS

Second Parkinson’s Group in Phase 1 Trial Receives ISCO’s Neural Stem Cell Therapy – Parkinson’s News Today

Continue reading

2018-03-09 Michael Zand NEWS

PET Scans Could Identify Those Likely to Respond to PD-1-targeted Cancer Therapies – Immuno-Oncology News

Immuno-Oncology NewsPET Scans Could Identify Those Likely to Respond to PD-1-targeted Cancer TherapiesImmuno-Oncology NewsPET scans could be a non-invasive way to identify patients likely to respond to cancer therapies targeting the PD-1 and PD-L1 prot… Continue reading

2018-03-09 Michael Zand NEWS

CRISPR/Cas9 technique suppresses malaria infection in mosquitos – Drug Target Review


Parkinson’s News Today

Second Parkinson’s Group in Phase 1 Trial Receives ISCO’s Neural Stem Cell Therapy
Parkinson’s News Today
A second group of Parkinson’s patients in a Phase 1 clinical trial have received International Stem Cell Corporation’s neural stem cell therapy. The main goal of the trial (NCT02452723) at Royal Melbourne Hospital is to see whether ISCO’s stem cell …

Continue reading

2018-03-09 Michael Zand NEWS

Global Synthetic Biology Market 2018- Amyris, DuPont, GenScript USA, Intrexon, New England Biolabs, New England … – New Mexico Courier Express

New Mexico Courier ExpressGlobal Synthetic Biology Market 2018- Amyris, DuPont, GenScript USA, Intrexon, New England Biolabs, New England …New Mexico Courier Express99strategy added a new latest industry research report that focuses on “Synthetic Bio… Continue reading

2018-03-09 Michael Zand NEWS

Dr. Andre on Questions With Immunotherapy in Triple-Negative Breast Cancer – OncLive

OncLiveDr. Andre on Questions With Immunotherapy in Triple-Negative Breast CancerOncLiveFabrice André, MD, professor, Department of Medical Oncology, Institut Gustave Roussy, discusses the remaining questions with immunotherapy agents as potential ther… Continue reading

2018-03-09 Michael Zand NEWS

Editas Medicine (EDIT) & Beyondspring (BYSI) Critical Contrast – StockNewsTimes

StockNewsTimesEditas Medicine (EDIT) & Beyondspring (BYSI) Critical ContrastStockNewsTimesIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribo… Continue reading

2018-03-09 Michael Zand NEWS

Stem cells could boost this Maryland baby’s heart and chance for a normal life – Baltimore Sun


Drug Target Review

CRISPR/Cas9 technique suppresses malaria infection in mosquitos
Drug Target Review
Using a gene-editing technique known as CRISPR/Cas9, scientists have shown that inactivating the gene FREP1 reduces mosquitos’ susceptibility to infection with Plasmodium, a genus of parasites that causes malaria in humans. Inside an Anopheles gambiae …

Continue reading

2018-03-09 Michael Zand NEWS
  • 1
  • …
  • 421
  • 422
  • 423
  • 424
  • 425
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Baltimore Sun

Stem cells could boost this Maryland baby’s heart and chance for a normal life
Baltimore Sun
Dr. Sunjay Kaushal, director of pediatric and adult congenital surgery at the University of Maryland and one of the nation’s foremost surgeons for hypoplastic left heart syndrome, said Autumn’s general health beyond the condition and her supportive …

and more »